Skip to main content
AUPH logo

AUPH · Aurinia Pharmaceuticals Inc. · Analyst Estimates

Track AUPH — free
$15.72 -0.11 (-0.69%) At close · Oct 5
Market Cap
$2.18B
Shares
133.05M
Volume · Oct 5 802.89K Avg daily vol (3M) 1.05M

Analyst Estimates

Compare analyst forecasts for Aurinia Pharmaceuticals Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-28 23:30 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.9
0.944
1.01
—
0.96
0.96
0.95
0.96
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
2
2
1
1
Revenue
USD
Publication date not stated
322186000
329107710
336500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.51
1.06667
1.64
—
1.115
1.115
1.10667
1.115
— — — —
EPS
analysts
Publication date not stated
— — —
6
— — — —
3
2
1
1
Revenue
USD
Publication date not stated
360000000
384396000
458978000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.21
0.22
0.25
—
0.2425
0.2425
0.238
0.2425
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
2
2
1
1
Revenue
USD
Publication date not stated
80400000
83149570
87200000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.16
0.2
0.25
—
0.24
0.24
0.226
0.24
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
2
2
0
0
Revenue
USD
Publication date not stated
83200000
85352860
88300000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —
Key facts CIK 1600620 CUSIP 05156V102 13F (30d) 4 filings 4 filers Visit website Investor relations